Conrad Rauber
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Molecular Biology top 2%
- Gut microbiota and health
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 9
-
- Liver Diseases and Immunity 3
- Co-authors
- Sebastian Schölch (3 shared papers)Peter Ernst Huber (3 shared papers)Jürgen Weitz (2 shared papers)Moritz Koch (2 shared papers)Christian Rupp (6 shared papers)María Paula Roberti (3 shared papers)Daniel Nils Gotthardt (5 shared papers)Ulrich Bork (1 shared paper)
- Journals
- Science (2 papers)United European Gastroenterology Journal (2 papers)JCI Insight (1 paper)Nature Medicine (1 paper)Oncotarget (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Conrad Rauber
24 papers receiving 5.8k citations
Conrad Rauber's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 2.5k
- Molecular Biology 2.9k
- Biotechnology 184
- Immunology 394
- Periodontics 99
Countries citing papers authored by Conrad Rauber
This map shows the geographic impact of Conrad Rauber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad Rauber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad Rauber more than expected).
Fields of papers citing papers by Conrad Rauber
This network shows the impact of papers produced by Conrad Rauber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad Rauber. The network helps show where Conrad Rauber may publish in the future.
Co-authors
The 25 scholars most cited alongside Conrad Rauber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors Hit paper breakdown → | 2017 | 4542 |
| 2 | Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade Hit paper breakdown → | 2020 | 334 |
| 3 | 2020 | 320 | |
| 4 | A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers Hit paper breakdown → | 2023 | 176 |
| 5 | 2020 | 170 | |
| 6 | 2014 | 60 | |
| 7 | 2022 | 59 | |
| 8 | Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients Hit paper breakdown → | 2025 | 38 |
| 9 | 2015 | 25 | |
| 10 | 2017 | 22 | |
| 11 | 2020 | 19 | |
| 12 | 2024 | 17 | |
| 13 | 2021 | 14 | |
| 14 | 2019 | 12 | |
| 15 | 2020 | 12 | |
| 16 | 2016 | 10 | |
| 17 | 2021 | 8 | |
| 18 | 2019 | 5 | |
| 19 | 2017 | 4 | |
| 20 | 2025 | 4 |
About Conrad Rauber
Conrad Rauber is a scholar working on Oncology, Hepatology, Immunology, Infectious Diseases and Molecular Biology, having authored 25 papers that have together received 5.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Gut microbiota and health (4 papers), Immunotherapy and Immune Responses (3 papers), Liver Diseases and Immunity (3 papers), COVID-19 Clinical Research Studies (2 papers), Organ Transplantation Techniques and Outcomes (2 papers), Bone health and osteoporosis research (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Oncology (2.5k citations), Molecular Biology (2.9k citations), Biotechnology (184 citations), Immunology (394 citations) and Periodontics (99 citations). Conrad Rauber has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Sebastian Schölch, Peter Ernst Huber, Jürgen Weitz, Moritz Koch, Christian Rupp, María Paula Roberti, Daniel Nils Gotthardt, Ulrich Bork, Rafael Carretero and Christoph Kahlert. Their work appears in journals such as Science, United European Gastroenterology Journal, JCI Insight, Nature Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.